Collier Kathryn J Insider Trades

Insider Trading History

Track insider trading activity for Collier Kathryn J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.58M 194,215 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $532k 65,240 shares
Last Trade
Jun 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.4k 4,929 shares
$8.20
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Jun 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.4k 4,929 shares
$8.20
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $554k 67,844 shares
Last Trade
Jun 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.5k 1,396 shares
$8.22
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $21.2k 2,604 shares
Last Trade
Jun 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.5k 1,396 shares
$8.22
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $565k 69,240 shares
Last Trade
Apr 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 62,500 shares
$7.98
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $55k 6,740 shares
Last Trade
Jul 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.28k 4,000 shares
$1.82
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $490k 60,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 60,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $245k 30,000 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.3k 30,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $122k 15,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 15,000 shares
$1.36
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $245k 30,000 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.5k 30,000 shares
$1.45
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $734k 90,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 90,000 shares
$2.67
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $326k 40,000 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 40,000 shares
$9.88
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $190k 23,250 shares
Last Trade
Jun 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 23,250 shares
$8.83
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $379k 46,500 shares
Last Trade
Oct 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$299k 46,500 shares
$6.44
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $225k 27,596 shares
Last Trade
Nov 16, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$102k 7,100 shares
$14.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $167k 20,496 shares
Last Trade
Nov 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$253k 16,874 shares
$15.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Nov 12, 2018 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$253k 16,874 shares
$15.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $62.8k 7,695 shares
Last Trade
Jun 05, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$683k 7,695 shares
$88.80
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $449k 55,000 shares
Last Trade
Jun 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.8M 55,000 shares
$87.34
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up